Senior insider sale
Chief Operating Officer at TARSUS PHARMACEUTICALS, INC. — senior position signals high conviction
$858.3K
11.49K shares
What this filing means
NEERVANNAN SESHADRI plans to sell 11.49K shares of TARSUS PHARMACEUTICALS, INC. valued at approximately $858.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/17/2026ACC: 0001959173-26-002439
Officer· Chief Operating Officer
Since Oct 2020
11.49K
Shares to sell
$858.3K
Approx. market value
3.13K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
3/16/2026
3.13KTotal acquired3.13K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/16/2026 | Restricted Stock Vesting Compensation | 3.13K | — |
| Total | 3.13K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
8.37K
Market value
$641.4K
3/4/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
3.13K
Market value
$216.9K
3/17/2026
Total
Units
11.49K
Value
$858.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/4/2026 | 8.37K | $641.4K | — | Completed |
| Planned — Approximate Date | ||||
3/17/2026 | 3.13K | $216.9K | NASDAQ | Planned |
| Total | 11.49K | $858.3K | ||